Plus, Netflix shares are up after reporting surpassing 200 million subscribers for the first time, Morgan Stanley delivered an earnings beat, and Procter & Gamble boosted its fiscal 2021 outlook.
Read MorePlus, Office Depot rejected another takeover offer from Staples, Microsoft is partnering with GM to invest in its Cruise self-driving startup, and Peloton shares are down following a downgrade from UBS.
Read MorePlus, Twitter shares are down after permanently banning Trump, bitcoin is down more than 20%, and Crocs shares are surging higher after raising its outlook for the year.
Read MorePlus, President Trump urged election officials in Georgia to flip the state to him, Google workers formed a union, and Brookfield Asset Management is offering to take its real estate arm private.
Read MoreBuy Price: $28.00 or better Sell Price: TradersPro Sell Signal Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. Its single molecule real-time (SMRT) sequencing technology enables single molecule real-time detection of biological processes. The company also provides consumable products, including SMRT cells, as well as various reagent […]
Read MorePlus, weekly jobless claims unexpectedly fell, Amazon is buying podcasting firm Wondery, and Enphase Energy will be added to the S&P 500 next month.
Read MorePlus, Novavax started its late-stage coronavirus vaccine trail in the U.S., Myovant shares are surging on news that it has partnered with Pfizer, and bitcoin rose to more than $28,000 over the weekend.
Read MorePlus, Congress passed a massive coronavirus relief and government spending package, Peloton is buying fitness equipment maker Precor, and cryptocurrency XRP has plunged after its parent company, Ripple, said it is being sued by the SEC.
Read MorePlus, Moderna’s COVID-19 vaccine was approved for emergency use by the FDA, Tesla shares are down on its first day in the S&P 500, and Nike shares are up after an earnings beat.
Read MoreBuy Price: $40.00 or better Sell Price: TradersPro Sell Signal Forte Biosciences Inc. operates as a clinical-stage dermatology company in the United States. It is developing a live biotherapeutic FB-401 that has completed Phase 1/2a clinical trial to treat inflammatory skin diseases for pediatric atopic dermatitis patients. The company is based in Torrance, California. The […]
Read MorePlus, CVS Health and Walgreens are starting to offer COVID-19 vaccinations for residents and staff at long-term care facilities, Darden Restaurants shares are down after disappointing earnings, and Dick’s Sporting Goods has teamed up with Instacart to offer same-day shipping.
Read MoreFor investors looking for bargains, these 3 unloved stocks could soon be bouncing back. Here’s what you need to know now.
Read MorePlus, the Electoral College confirmed President-elect Joe Biden’s win, Spotify inked an exclusive deal with Prince Harry and wife Meghan for podcasts from their new production company, and Apple shares are up on reports of increased production for its latest iPhones.
Read MoreIn a stock picker’s market, stocks like these 5 names are the ones to watch. Here’s why.
Read MoreBuy Price: $130.00 or better Sell Price: TradersPro Sell Signal Novavax, Inc., together with its subsidiary, Novavax AB, a late-stage biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases. The company’s lead vaccine candidates include ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate that […]
Read More